gsk2256098
Showing 1 - 4 of 4
Pancreatic Cancer, Adenocarcinoma Trial in Canada (GSK2256098, Trametinib)
Active, not recruiting
- Pancreatic Cancer
- Adenocarcinoma
- GSK2256098
- Trametinib
-
Hamilton, Ontario, Canada
- +3 more
May 12, 2022
Cancer Trial in Melbourne (GSK2256098, Placebo)
Completed
- Cancer
- GSK2256098
- Placebo
-
Melbourne, Victoria, AustraliaGSK Investigational Site
Jun 13, 2017
Cancer Trial in Australia, France, United Kingdom (GSK2256098)
Completed
- Cancer
- GSK2256098
-
Heidelberg, Victoria, Australia
- +9 more
May 10, 2017